Company Filing History:
Years Active: 2013
Title: Alistair Selkirk: Innovator in Pharmaceutical Formulations
Introduction
Alistair Selkirk is a notable inventor based in Dundee, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative formulations. His work focuses on enhancing the efficacy and delivery of pharmaceutical compounds.
Latest Patents
Selkirk holds a patent for "Crystalline pyrimidine nucleoside derivative suspensions in capsules." This invention relates to a pharmaceutical formulation that comprises a capsule and a core containing crystalline 2'-cyano-2'-deoxy-N-palmitoyl-1-β-D-arabinofuranosylcytosine along with a liquid carrier. This formulation aims to improve the stability and bioavailability of the active ingredients.
Career Highlights
Throughout his career, Alistair Selkirk has been associated with Cyclacel Limited, a company known for its focus on innovative cancer therapies. His work at Cyclacel has allowed him to contribute to the advancement of pharmaceutical science and improve treatment options for patients.
Collaborations
Selkirk has collaborated with various professionals in the field, including his coworker Robert Westwood. These collaborations have fostered a productive environment for innovation and research within the company.
Conclusion
Alistair Selkirk's contributions to pharmaceutical formulations exemplify the impact of innovative thinking in medicine. His patent and work at Cyclacel Limited highlight the importance of developing effective drug delivery systems.